CDRH’s Shuren Calls For ‘Reset’ Of FDA Medtech Initiatives

Programs disrupted by COVID-19 would be restarted in 2021 to guide developers on clinical decision support software, produce safe OTC hearing aids

Reset after COVID-19

More from Regulation

More from Policy & Regulation